Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Authors:
- Gretchen M. AliceaGAGretchen M. Alicea
- Payal PatelPPPayal Patel
- Marie E. PortualloMPMarie E. Portuallo
- Mitchell E. FaneMFMitchell E. Fane
- Meihan WeiMWMeihan Wei
- Yash ChhabraYCYash Chhabra
- Agrani DixitADAgrani Dixit
- Alexis E. CareyACAlexis E. Carey
- Vania WangVWVania Wang
- Murilo R. RochaMRMurilo R. Rocha
- Reeti BeheraRBReeti Behera
- David W. SpeicherDSDavid W. Speicher
Open Access
- 1 August 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 4 (8) , 1908-1918
Abstract
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to those co-cultured with young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts or overexpressing IGFBP2 in melanoma cells promoted lipid synthesis and accumulation in melanoma cells. Treatment of young mice with rIGFBP2 increases tumor growth. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice reduces tumor growth and metastasis. Our results suggest that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment. Significance: The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces lipid accumulation in melanoma cells, driving an increase in tumor invasiveness. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma ProgressionJournal of Visualized Experiments, 2011
- Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelBritish Journal of Cancer, 2011
- Senescent cells as a source of inflammatory factors for tumor progressionCancer and Metastasis Reviews, 2010
- Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous CarcinomasJournal of Oncology, 2010
- Antidiabetic Effects of IGFBP2, a Leptin-Regulated GeneCell Metabolism, 2010
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stromaCell Cycle, 2009
- Lipid Rafts and Caveolin-1 Are Required for Invadopodia Formation and Extracellular Matrix Degradation by Human Breast Cancer CellsCancer Research, 2009
- Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancerProceedings of the National Academy of Sciences, 2007
- Characterization of Insulin-Like Growth Factor-Binding Protein-Related Proteins (IGFBP-rPs) 1, 2, and 3 in Human Prostate Epithelial Cells: Potential Roles for IGFBP-rP1 and 2 in Senescence of the Prostatic Epithelium*Endocrinology, 2000
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI: Journal of the National Cancer Institute, 2000